PS38 | IICIMED

Cultural differences in attitudes towards surgical site infections among French anesthetists and surgeons in digestive surgery in 2022.

PS38

Antimicrob. Resist. Infect. Control. 2025, 14, 57.

Cultural differences in attitudes towards surgical site infections among French anesthetists and surgeons in digestive surgery in 2022.


https://doi.org/10.1186/s13756-025-01576-9

PS37 | IICIMED

Evolution of the GP2A network over the past 30 years and annual conference locations.

PS37

J. Med. Chem. 2025, 68, 2045–2047.

Shaping future medicinal chemists: Perspectives from European schools of Pharmacy within the GP2A network.


https://doi.org/10.1021/acs.jmedchem.4c03103

PS36 | IICIMED

Cellular inhibition percentage of compounds BV3 and BV5 in the normal L929 cell line and the tumor cell lines HCT-116, HepG2, MDA-MD-231, and HeLa obtained through the MTT test.

PS36

Pharmaceuticals 2025, 18, 837.

New insights into the anticancer effects and toxicogenomic safety of two β-Lapachone derivatives.


https://doi.org/10.3390/ph18060837

PS35 | IICIMED

Geographical distribution of NDM-producing K pneumoniae patients in the intensive care unit. NDM, New Delhi metallo-β-lactamase.

PS35

 Am. J. Infect. Control. 2025, 53, 648–651.

Hospital outbreak of NDM-producing Klebsiella pneumoniae in a surgical intensive care unit: Sink traps as the causing source of epidemic strain resurgence.


https://doi.org/10.1016/j.ajic.2025.01.003

PS34 | IICIMED

Systematic screening for EPC digestive carriage in repatriates and patients with past history of hospitalization abroad within one year at Nantes University Hospital admission.

PS34

Infect. Dis. Now. 2025, 55, 105021.

Epidemiological and bacteriological trends from 2013 to 2023 of carbapenemase-producing enterobacterales (CPE) in a French university hospital: A permanent risk of outbreak.


https://doi.org/10.1016/j.idnow.2024.105021